Skip to Content
Merck
  • Halogenation of N⁶-benzyladenosine decreases its cytotoxicity in human leukemia cells.

Halogenation of N⁶-benzyladenosine decreases its cytotoxicity in human leukemia cells.

Toxicology in vitro : an international journal published in association with BIBRA (2010-07-20)
Petr Dolezel, Petra Koudelkova, Petr Mlejnek
ABSTRACT

Cytotoxicity of two halogen derivatives of N⁶-benzyladenosine (BAPR), N⁶-(3-iodobenzyl)-adenosine (I-BAPR) and 2-chloro-N⁶-(3-iodobenzyl)-adenosine (Cl-I-BAPR), was tested in human leukemia U937 cell line. Our results revealed that their cytotoxicity was surprisingly low. I-BAPR and also Cl-I-BAPR induced cell death with morphological and biochemical hallmarks of apoptosis, although the number of apoptotic cells was significantly lower than that found for BAPR. Our data strongly suggested that the decreased cytotoxic effect of halogenated derivatives of N⁶-benzyladenosine was related to their reduced intracellular phosphorylation by adenosine kinase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N6-Benzyladenosine, ≥99.0%